跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cefatrene - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Cefatrene
Approved
STANDARD
Cefatrene
J.M. Tolmann Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f3950a57dcda69aa
Company
J.M. Tolmann Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
f3950a57dcda69aa
Drug Approval Philippines Name
Cefatrene
Product Name
Cefatrene
Registration Number
DRP-130-03
Brand Name
Cefatrene
Generic Name
Cefalexin (As Monohydrate)
Dosage Form
Powder For Suspension (Oral Drops)
Dosage Strength
100 mg / mL
Manufacturer
J.M. Tolmann Laboratories, Inc.
Distributor
FARMA IBERICA CORPORATION
Issuance Date
25 May 2022
Expiry Date
30 May 2027
Pharmacologic Category
ANTIBACTERIALS (CEPHALOSPORINS)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f3950a57dcda69aa
Type
Standard
Back to Philippines FDA Approvals